Predicting progression to Alzheimer’s disease from clinical and imaging data: a reproducible study

Abstract : Various machine learning approaches have been developed for predicting progression to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI) from MRI and PET data. Objective comparison of these approaches is nearly impossible because of differences at all steps, from data management to image processing and evaluation procedures. Moreover, with a few exceptions, these papers rarely compare their results to that obtained with clinical/cognitive data only, a critical point to demonstrate the practical utility of neuroimaging in this context. We previously proposed a framework for the reproducible evaluation of ML algorithms for AD classification. This framework was applied to AD classification using unimodal neuroimaging data (T1 MRI and FDG PET). Here, we extend our previous work to the combination of multimodal clinical and neuroimaging data for predicting progression to AD among MCI patients. All the code is publicly available at: https://gitlab.icm-institute.org/aramislab/AD-ML.
Document type :
Conference papers
Complete list of metadatas

Cited literature [5 references]  Display  Hide  Download

https://hal.inria.fr/hal-02142315
Contributor : Jorge Samper-Gonzalez <>
Submitted on : Tuesday, May 28, 2019 - 3:05:15 PM
Last modification on : Wednesday, May 29, 2019 - 1:49:58 AM

File

OHBM Jorge .pdf
Files produced by the author(s)

Identifiers

  • HAL Id : hal-02142315, version 1

Citation

Jorge Samper-Gonzalez, Ninon Burgos, Simona Bottani, Marie-Odile Habert, Theodoros Evgeniou, et al.. Predicting progression to Alzheimer’s disease from clinical and imaging data: a reproducible study. OHBM 2019 - Organization for Human Brain Mapping Annual Meeting 2019, Jun 2019, Rome, Italy. ⟨hal-02142315⟩

Share

Metrics

Record views

131

Files downloads

251